Renos Pharma Private Limited
About Renos Pharma Private Limited
Data last updated:
Renos Pharma Private Limited is a private limited company based in Palakkad, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51397KL2016PTC040395. Its GSTIN is 32AAHCR6888B1Z9 (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anil Achuthannair (Managing Director) and Sunil Pai Dayananda.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 21/555(8) Adithya Nagar Nurani (P.O.), Palakkad, Kerala, India – 678004.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.39 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹3.13 Lakh (net margin -0.9%) and EBITDA of ₹3.41 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address21/555(8) Adithya Nagar Nurani (P.O.), Palakkad, Kerala, India – 678004
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Renos Pharma Private Limited
The main business activity of Renos Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Renos Pharma Private Limited FY 2024 filings available
Renos Pharma Private Limited reported revenue of ₹3.39 Cr (up 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Renos Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 7% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Renos Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.41 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Renos Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Renos Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Renos Pharma Private Limited
Renos Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enerplus Energy Private Limited | ₹3.41 Cr (FY 2024) | •••• | •••• | 89.0% | •••• | Mumbai, Maharashtra, India |
| Revlish Life Science Private Limited | ₹3.4 Cr (FY 2025) | •••• | •••• | 5008.0% | •••• | Delhi, India |
| Tyscon Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Zirakpur, Punjab, India |
| Astha Laboratories Private Limited | ₹3.4 Cr (FY 2019) | •••• | •••• | -10.0% | •••• | Hyderabad, Telangana, India |
| Foursa Medicare Private Limited | ₹3.39 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Meerut, Uttar Pradesh, India |
| Renos Pharma Private Limited this company | ₹3.39 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Palakkad, Kerala, India |
| Feednetic India Private Limited | ₹3.39 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Nelamangala, Karnataka, India |
| VS Enterprises Private Limited | ₹3.38 Cr (FY 2024) | •••• | •••• | -85.0% | •••• | Kochi, Kerala, India |
| Salubria Pharmaventures Private Limited | ₹3.38 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Nagpur, Maharashtra, India |
| Xorptech Lifescience Private Limited | ₹3.38 Cr (FY 2022) | •••• | •••• | 55.0% | •••• | Ahmedabad, Gujarat, India |
| Sanaka Medical Private Limited | ₹3.37 Cr (FY 2025) | •••• | •••• | 165.0% | •••• | Durgapur, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Renos Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Renos Pharma Private Limited
Renos Pharma has 7 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Pai Dayananda | Director | 16 May 2016 | 10 Years 4 Months | Current |
| Girishkumar Chandrasekarannair Mukkattu | Director | 16 May 2016 | 10 Years 4 Months | Current |
| Jiji Chakkalakkal | Director | 17 Mar 2016 | 10 Years 6 Months | Current |
| Prasanth Padinareveettil | Director | 16 May 2016 | 10 Years 4 Months | Current |
| Sudheesh Unni Krishnan | Director | 16 May 2016 | 10 Years 4 Months | Current |
| Anil Achuthannair | Managing Director | 17 Mar 2016 | 10 Years 6 Months | Current |
Ownership and Shareholding of Renos Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Renos Pharma Private Limited
Renos Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Renos Pharma Private Limited
Employment history and EPFO contributions of people linked to Renos Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Renos Pharma Private Limited
Renos Pharma Private Limited has 13 board changes on record since 2016: 7 appointments and 6 cessations. The latest: Anil Achuthannair ceased to be Managing Director on 29 Dec 2017.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Renos Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Renos Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Renos Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Renos Pharma Private Limited
Renos Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAHCR6888B1Z9 | Kerala | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Renos Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Renos Pharma Private Limited
Renos Pharma is an active private limited company based in Palakkad, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 March 2016 (10+ years old) and is registered under CIN U51397KL2016PTC040395.
Renos Pharma reported revenue of ₹3.39 Cr for FY 2024 (up 7% YoY).
Renos Pharma has 7 current directors:
- Anil Achuthannair - Managing Director
- Sunil Pai Dayananda - Director
- Girishkumar Chandrasekarannair Mukkattu - Director
- Jiji Chakkalakkal - Director
- Prasanth Padinareveettil - Director
- Sudheesh Unni Krishnan - Director
- Ranjith Rangarajan - Director
Renos Pharma reported a net loss of ₹3.13 Lakh (net margin -0.9%) and EBITDA of ₹3.41 Lakh (EBITDA margin 1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Renos Pharma is 9% over three years and 13% over five years. In the latest year (FY 2024) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Renos Pharma is 32AAHCR6888B1Z9, registered in Kerala.
The CIN (Corporate Identification Number) of Renos Pharma is U51397KL2016PTC040395. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Renos Pharma was incorporated on 17 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Renos Pharma by revenue are Enerplus Energy Private Limited, Revlish Life Science Private Limited, Tyscon Pharmaceuticals Private Limited, Astha Laboratories Private Limited, Foursa Medicare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Anil Achuthannair ceased to be Managing Director on 29 Dec 2017. Girishkumar Chandrasekarannair Mukkattu ceased to be Director on 29 Dec 2017. Prasanth Padinareveettil ceased to be Director on 29 Dec 2017. Renos Pharma has 13 board changes on record in total.
The registered office of Renos Pharma is at 215558 Adithya Nagar Nurani P.O., Palakkad, Kerala, India – 678004.